XML 40 R12.htm IDEA: XBRL DOCUMENT
v3.20.1

Share-Based Payments | 3 Months Ended
--- | ---
Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Share-Based Payments | Share-Based Payments The Company’s general practice has been to make a single annual grant of share-based compensation in the first quarter to key employees and to make other employee grants only in connection with new employment or promotions. Forms of share-based compensation granted to employees by the Company include stock options, non-vested shares of common stock (“non-vested shares”), and performance shares. The Company also typically makes a single annual grant of non-vested shares to non-employee directors in conjunction with the annual election of non-employee directors to the Board of Directors. Share-based compensation is based on the grant date fair value of the instrument and is recognized ratably over the requisite service period, or vesting period. All share-based compensation expense is recognized in salaries, wages and employee benefits. Employee Activity - Stock Options Stock option grants to employees generally expire seven years from the grant date and typically vest ratably over a three-year period. All forfeitures were recognized as they occurred. The Company used the Black-Scholes option-pricing model to estimate the grant-date fair value of options granted. There were no options granted during the three months ended March 31, 2019. The weighted-average fair value of options granted and assumptions used to estimate their fair value during the three months ended March 31, 2020 were as follows:
| Three months ended
| March 31, 2020
Expected dividend yield | 1.1 | %
Expected stock price volatility | 24.1 | %
Weighted average risk-free interest rate | 1.5 | %
Expected life of options (years) | 5.9 |
Weighted average grant date fair value | $ | 14.79 |
The following tables summarize the Company’s employee stock option activity and related information:
| Three months ended March 31, 2020
|  |  |  |  |  |  | Weighted-
|  |  | Weighted- |  |  |  | Average
|  |  | Average |  | Aggregate |  | Remaining
|  |  | Exercise |  | Intrinsic |  | Contractual
| Options |  | Price |  | Value |  | Term
Outstanding at December 31, 2019 | 431 |  |  | $ | 53 |  |  |  |  |
Granted | 36 |  |  | 66 |  |  |  |  |
Exercised | — |  |  | — |  |  |  |  |
Forfeited | (2 | ) |  | 60 |  |  |  |  |
Outstanding at March 31, 2020 | 465 |  |  | $ | 54 |  |  | $ | 3,017 |  |  | 4.1
Exercisable at March 31, 2020 | 330 |  |  | $ | 51 |  |  | $ | 3,364 |  |  | 3.5
| Three months ended
| March 31, 2020 |  | March 31, 2019
Share-based compensation for options | $ | 327 |  |  | $ | 439 |
Tax benefit for option compensation | $ | 75 |  |  | $ | 105 |
Unrecognized compensation cost for options | $ | 1,671 |  |  | $ | 2,768 |
Weighted average period over which unrecognized compensation will be recognized (years) | 1.7 |  |  |
Employee Activity - Non-vested Shares The fair value of non-vested shares issued was estimated using the closing market prices for the business day of the grant. The share-based compensation for the nonvested shares is recognized ratably over the requisite service period or vesting period, which is a three-year period. All forfeitures were recognized as they occurred. The following tables summarize the Company’s employee non-vested share activity and related information:
| Three months ended March 31, 2020
|  |  | Weighted- |  |
|  |  | Average |  | Aggregate
| Non-vested |  | Grant Date |  | Grant Date
| Shares |  | Fair Value |  | Fair Value
Outstanding and non-vested at December 31, 2019 | 277 |  |  | $ | 58 |  |  |
Granted | 117 |  |  | 66 |  |  |
Vested | (104 | ) |  | 67 |  |  |
Forfeited | (6 | ) |  | 62 |  |  |
Outstanding and non-vested at March 31, 2020 | 284 |  |  | $ | 63 |  |  | $ | 17,758 |
| Three months ended
| March 31, 2020 |  | March 31, 2019
Share-based compensation for non-vested shares | $ | 1,938 |  |  | $ | 2,042 |
Tax benefit for non-vested share compensation | $ | 442 |  |  | $ | 486 |
Unrecognized compensation cost for non-vested shares | $ | 13,963 |  |  | $ | 15,251 |
Weighted average period over which unrecognized compensation will be recognized (years) | 2.2 |  |  |
Employee Activity - Performance Shares The Company annually grants performance shares to key employees. Under the terms of the performance share agreements, following the end of a three-year performance period, the Company may issue to these employees a calculated number of common stock shares if certain performance targets are met. For shares granted during the three months ended March 31, 2020 and 2019, 50% of the performance share issuances will be based on meeting three-year earnings before interest, taxes, depreciation and amortization ("EBITDA") per share targets and the remaining 50% of the performance share issuances will be based on the three-year performance of the Company’s total shareholder return ("TSR") as compared to the TSR of a selected peer group. All forfeitures were recognized as they occurred. Depending upon the EBITDA per share targets met, 0% to 200% of the granted shares may ultimately be issued. For shares granted based on total shareholder return, 0% of the shares will be issued if the Company's total shareholder return outperforms 25% or less of the peer group, but 200% of the shares will be issued if the Company's total shareholder return performs better than 90% of the peer group. The fair value of the performance shares granted based on meeting EBITDA per share targets were estimated using the closing market prices on the day of grant and the probability of meeting these targets as of the measurement date. The fair value of the performance shares granted based on the three-year performance of the Company’s total shareholder return was estimated using a Monte Carlo simulation. The following table contains the weighted-average assumptions used to estimate the fair value of performance shares granted using the Monte Carlo simulation. These assumptions are subjective and changes in these assumptions can materially affect the fair value estimate.
| Three months ended
| March 31, 2020 |  | March 31, 2019
Expected stock price volatility | 23.5 | % |  | 23.4 | %
Weighted average risk-free interest rate | 1.4 | % |  | 2.5 | %
The following tables summarize the Company’s employee performance share activity, assuming median share awards, and related information:
| Three months ended March 31, 2020
|  |  | Weighted- |  |
|  |  | Average |  | Aggregate
| Performance |  | Grant Date |  | Grant Date
| Shares |  | Fair Value |  | Fair Value
Outstanding and non-vested at December 31, 2019 | 62 |  |  | $ | 62 |  |  |
Granted | 40 |  |  | 69 |  |  |
Additional shares awarded based on performance | 13 |  |  | 51 |  |  |
Vested | (35 | ) |  | 51 |  |  |
Forfeited | (4 | ) |  | 66 |  |  |
Outstanding and non-vested at March 31, 2020 | 76 |  |  | $ | 67 |  |  | $ | 5,135 |
| Three months ended
| March 31, 2020 |  | March 31, 2019
Share-based compensation for performance shares | $ | 740 |  |  | $ | 348 |
Tax benefit for performance share compensation | $ | 169 |  |  | $ | 83 |
Unrecognized compensation cost for performance shares | $ | 3,695 |  |  | $ | 2,806 |
Weighted average period over which unrecognized compensation will be recognized (years) | 2.5 |  |  |
Employee Activity – Employee Stock Purchase Plan Under the 2005 Employee Stock Purchase Plan (the “ESPP”), which has been approved by shareholders, the Company is authorized to issue up to a remaining 350 shares of common stock to employees of the Company. These shares may be issued at a price equal to 90% of the lesser of the market value on the first day or the last day of each six-month purchase period. Common stock purchases are paid for through periodic payroll deductions and/or up to two large lump sum contributions. There were no shares issued during the three months ended March 31, 2020.
Non-employee Director Activity - Non-vested Shares In May 2006, the Company’s shareholders approved the Company’s 2006 Non-Employee Director Stock Plan (the “2006 Plan”). The Company’s shareholders then approved the Company’s Amended and Restated Non-Employee Director Stock Plan (the “Amended Plan”) on May 22, 2007. The Amended Plan was then further amended and restated on December 17, 2008. Under the Amended Plan, on the first business day after each Annual Meeting of Shareholders, each non-employee director will automatically be granted an award (the “Annual Grant”), in such form and size as the Board determines from year to year. Unless otherwise determined by the Board, Annual Grants will become vested and nonforfeitable on the earlier of (a) the day immediately prior to the first Annual Meeting that occurs after the Grant Date or (b) the first anniversary of the Grant Date so long as the non-employee director’s service with the Company does not earlier terminate. Each director may elect to defer receipt of the shares under a non-vested share award until the director terminates service on the Board of Directors. If a director elects to defer receipt, the Company will issue deferred stock units to the director, which do not represent actual ownership in shares and the director will not have voting rights or other incidents of ownership until the shares are issued. However, the Company will credit the director with dividend equivalent payments in the form of additional deferred stock units for each cash dividend payment made by the Company. All forfeitures were recognized as they occurred. In May 2016, with the approval of shareholders, the Company further amended the Amended Plan to reserve for issuance an additional 160 common shares, increasing the total number of reserved common shares under the Amended Plan to 360. As of March 31, 2020, there were approximately 116 shares remaining available for grant. The following tables summarize the Company’s non-employee non-vested share activity and related information:
| Three months ended March 31, 2020
|  |  | Weighted- |  |
|  |  | Average |  | Aggregate
| Non-vested |  | Grant Date |  | Grant Date
| Shares |  | Fair Value |  | Fair Value
Outstanding and non-vested at December 31, 2019 | 16 |  |  | $ | 62 |  |  |
Granted | — |  |  | — |  |  |
Vested | — |  |  | — |  |  |
Forfeited | — |  |  | — |  |  |
Outstanding and non-vested at March 31, 2020 | 16 |  |  | $ | 62 |  |  | $ | 990 |
| Three months ended
| March 31, 2020 |  | March 31, 2019
Share-based compensation for non-vested shares | $ | 261 |  |  | $ | 218 |
Tax benefit for non-vested share compensation | $ | 60 |  |  | $ | 52 |
Unrecognized compensation cost for non-vested shares | $ | 106 |  |  | $ | 142 |
Weighted average period over which unrecognized compensation will be recognized (years) | 0.1 |  |  |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration